Medtech stories we missed this week: August 3, 2018

From Esaote launching its new ultrasound device to Nipro’s Infraredx launching in Japan, here are seven medtech stories we missed this week but thought were still worth mentioning.

1. Esaote launches new ultrasound devices

Esaote announced in an Aug. 2 press release that it has launched its new MyLab X7, MyLab X6 and MyLab X5 ultrasound systems. The MyLab X7 offers faster and more reliable ultrasounds with intuitive usability and ergonomics. MyLab X5 has zero-click automatic that speeds up assessments and enhances image quality.

2. Bonesupport inks deal with MTF Biologics

Bonesupport and MTF Biologics have signed an agreement to extend and strengthen Bonesupport’s product offerings in the U.S., according to an Aug. 2 press release. Bonesupport will receive rights to two forms of bone graft materials that are made from 100% demineralized bone matrix. The products supplied by MTF Biologics will be launched under the Bonesupport name through its own U.S. distribution network.

3. Canada approves Mindshare Medical’s lung cancer diagnosis software

Mindshare Medical announced in an Aug. 2 press release that it has received Health Canada approval for its RevealAI-Lung product. The product is a computer-assisted diagnostic software program for lung cancer diagnosis. It helps clinicians improve diagnostic efficacy while optimizing recommendations for follow-up. The technology uses a radiomics approach that generates a malignancy similarity index that has hundreds of characteristics from the CT that are combined into a morphological biomarker of malignancy. The biomarker can then be used to compare the nodule being diagnosed with nodules in the company’s reference database with known diagnostics and outcomes.

Get the full story on our sister site, MassDevice. 

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW